Viewing Study NCT04611802


Ignite Creation Date: 2025-12-25 @ 3:39 AM
Ignite Modification Date: 2025-12-26 @ 2:23 AM
Study NCT ID: NCT04611802
Status: COMPLETED
Last Update Posted: 2023-12-21
First Post: 2020-10-30
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study to Evaluate the Efficacy, Immune Response, and Safety of a COVID-19 Vaccine in Adults ≥ 18 Years With a Pediatric Expansion in Adolescents (12 to<18 Years) at Risk for SARS-CoV-2
Sponsor: Novavax
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2020-12-27
Start Date Type: ACTUAL
Primary Completion Date: 2023-04-10
Primary Completion Date Type: ACTUAL
Completion Date: 2023-12-15
Completion Date Type: ACTUAL
First Submit Date: 2020-10-30
First Submit QC Date: None
Study First Post Date: 2020-11-02
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: 2023-07-25
Disp First Post Date Type: ACTUAL
Last Update Submit Date: 2023-12-19
Last Update Post Date: 2023-12-21
Last Update Post Date Type: ACTUAL